dc.contributor.author | Souza, Marina de Assis | |
dc.contributor.author | Castro, Maria C. A. Brelaz de | |
dc.contributor.author | Oliveira, Andresa Pereira de | |
dc.contributor.author | Almeida, Amanda Ferreira de | |
dc.contributor.author | Almeida, Thays Miranda de | |
dc.contributor.author | Reis, Luiza C. | |
dc.contributor.author | Medeiros, Angela Cristina Rapela | |
dc.contributor.author | Brito, Maria Edileuza Felinto de | |
dc.contributor.author | Pereira, Valeria Rego Alves | |
dc.date.accessioned | 2024-10-21T18:46:44Z | |
dc.date.available | 2024-10-21T18:46:44Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Microb. Pathog. | |
dc.identifier.uri | http://dx.doi.org/10.1016/j.micpath.2013.02.004 | |
dc.identifier.uri | https://repositorio.maua.br/handle/MAUA/1497 | |
dc.description.abstract | Studies suggest the influence of immune response on the successful treatment of American tegumentary leishmaniasis (ATL), and indicate the existence of protective immunity in self-healed patients. Thus, the aim of this work was to quantify interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF-alpha), interleukin (IL-) 10, IL-17, IL-22 and nitric oxide (NO) in culture supernatants of PBMC from patients with active disease (AD), after treatment (AT), and from self-healed (SH) and healthy subjects (CT), in response to Leishmania (Viannia) braziliensis insoluble antigen (AgIns). All groups of patients produced IFN-gamma, indicating a predominant proinflammatory profile. AD and AT patients presented TNF-alpha levels, with a slight increase after therapy, whereas it was weakly quantified in SH. Interestingly, NO secretion was significant in these individuals, whereas IL-17 appeared in low levels and seems to be regulated by NO. Although IL-22 was detected in AD, its role is still questionable. The presence of IL-10 in all groups of patients suggests that the cytokine plays distinct roles in the disease. These results indicate that specific cellular immunity takes part against Leishmania, but with some similarities between the different clinical states herein described; these mediators seem to be necessary for the cure to occur. (C) 2013 Elsevier Ltd. All rights reserved. | en |
dc.description.sponsorship | CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)) | pt_BR |
dc.description.sponsorship | CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)) | pt_BR |
dc.description.sponsorship | FIOCRUZ | pt_BR |
dc.description.sponsorship | CAPES | |
dc.description.sponsorship | CNPq | |
dc.description.sponsorship | FIOCRUZ | |
dc.format.extent | 6.0 | |
dc.language | Inglês | pt_BR |
dc.publisher | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD | en |
dc.relation.ispartof | MICROBIAL PATHOGENESIS | |
dc.rights | Acesso Aberto | |
dc.source | Web of Science | en |
dc.subject | Cytokines | en |
dc.subject | Cellular immunity | en |
dc.subject | Leishmania braziliensis | en |
dc.subject | Leishmaniasis | en |
dc.subject | Nitric oxide | en |
dc.subject | CUTANEOUS LEISHMANIASIS | en |
dc.subject | MUCOSAL LEISHMANIASIS | en |
dc.subject | NITRIC-OXIDE | en |
dc.subject | IMMUNE-RESPONSES | en |
dc.subject | CLINICAL CURE | en |
dc.subject | MECHANISMS | en |
dc.subject | BRAZILIENSIS | en |
dc.subject | CHEMOTHERAPY | en |
dc.subject | PARASITES | en |
dc.subject | GENES | en |
dc.subject | Immunology | en |
dc.subject | Microbiology | en |
dc.subject.other | Cytokines | en |
dc.subject.other | Cellular immunity | en |
dc.subject.other | Leishmania braziliensis | en |
dc.subject.other | Leishmaniasis | en |
dc.subject.other | Nitric oxide | en |
dc.subject.other | CUTANEOUS LEISHMANIASIS | en |
dc.subject.other | MUCOSAL LEISHMANIASIS | en |
dc.subject.other | NITRIC-OXIDE | en |
dc.subject.other | IMMUNE-RESPONSES | en |
dc.subject.other | CLINICAL CURE | en |
dc.subject.other | MECHANISMS | en |
dc.subject.other | BRAZILIENSIS | en |
dc.subject.other | CHEMOTHERAPY | en |
dc.subject.other | PARASITES | en |
dc.subject.other | GENES | en |
dc.subject.other | Immunology | en |
dc.subject.other | Microbiology | en |
dc.title | Cytokines and NO in American tegumentary leishmaniasis patients: Profiles in active disease, after therapy and in self-healed individuals | en |
dc.type | Artigo de Periódico | pt_BR |
dc.identifier.doi | 10.1016/j.micpath.2013.02.004 | |
dc.description.affiliation | Fundacao Oswaldo Cruz | |
dc.description.affiliation | Universidade de Sao Paulo | |
dc.description.affiliation | Instituto Maua de Tecnologia | |
dc.description.affiliation | Universidade Federal de Pernambuco | |
dc.identifier.wos | WOS:000316921400005 | |
dc.contributor.orcid | Reis, Luiza Campos/0000-0001-5412-4066 | |
dc.contributor.orcid | Alves Pereira, Valeria Rego/0000-0002-7995-7360 | |
dc.contributor.orcid | Castro, Maria Carolina/0000-0003-2205-0618 | |
dc.contributor.orcid | De Assis Souza, Marina/0000-0003-2540-3706 | |
dc.citation.epage | 32 | |
dc.citation.spage | 27 | |
dc.citation.volume | 57 | |